New perspectives in the treatment of hidradenitis suppurativa: Surgery and brewer's yeast–exclusion diet


      Hidradenitis suppurativa (HS), or acne inversa, is a chronic inflammatory skin disease characterized by abscesses, fistulating sinus tracts, and scarring. The exact pathogenesis of this disease remains unclear. We present our experience with HS and a possible cause of the disease and offer a surgical and clinical treatment that allows for disease resolution.


      We studied 12 patients who presented with axillary and perineal fistulas and underwent surgical excision (repaired by skin grafts or healing by secondary intention) or localized treatments followed by diet modification. All patients were found to have a specific immunology IgG reaction to brewer's yeast and wheat and were put on a controlled brewer's yeast–free diet for 12 months and followed monthly.


      The diet demonstrated immediate stabilization of their clinical symptoms, and the skin lesions regressed over the 12-month treatment period. Similarly, all the patients demonstrated an immediate recurrence of skin lesions following accidental or voluntary consumption of beer or other foods containing brewer's yeast or wheat. The patients also demonstrated a return of their quality of life and activities, including the reestablishment of sexual activity in the patients with inguinal and perigenital lesions.


      The results of the investigation suggested that the patients had severe reactions to brewer's yeast. Surgery followed by the elimination of the foods containing or made with the yeast resulted in a rapid stabilization of the dermatologic manifestation and a slow, but complete, regression of the skin lesions within a year. Despite the small number of patients in our study, our study could provide the basis for extensive and multicentric studies in order to better investigate this disabling and rare disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Buimer M.G.
        • Wobbes T.
        • Klinkenbijl J.H.
        Hidradenitis suppurativa.
        Br J Surg. 2009; 96: 350-360
        • Brown S.C.
        • Kazzazi N.
        • Lord P.H.
        Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form.
        Br J Surg. 1986; 73: 978-980
        • Edlich R.F.
        • Silloway K.A.
        • Rodeheaver G.T.
        • Cooper P.H.
        Epidemiology, pathology, and treatment of axillary hidradenitis suppurativa.
        Emerg Med. 1986; 4: 369-378
        • Kagan R.J.
        • Yakuboff K.P.
        • Warner P.
        • Warden G.D.
        Surgical treatment of hidradenitis suppurativa: a 10-year experience.
        Surgery. 2005; 138: 734-740
        • Anstey A.V.
        • Wilkinson J.D.
        • Lord P.
        Squamous cell carcinoma complicating hidradenitis suppurativa.
        Br J Dermatol. 1990; 123: 527-531
        • Losanoff J.E.
        • Sochaki P.
        • Khoury N.
        • et al.
        Squamous cell carcinoma complicating chronic suppurative hydradenitis.
        Am Surg. 2011; 77: 1449-1453
        • Revuz J.
        Antibiotic treatment of hidradenitis suppurativa.
        Ann Dermatol Venereol. 2012; 39: 532-541
        • Camisa C.
        • Sexton C.
        • Friedman C.
        Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression: a case report.
        J Reprod Med. 1989; 34: 543-546
        • Blok J.L.
        • van Hattem S.
        • Jonkman M.F.
        • Horváth B.
        Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review.
        Br J Dermatol. 2013; 168: 243-252
        • Van Rappard D.C.
        • Mekkes J.R.
        Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.
        Br J Dermatol. 2012; 167: 206-208
        • van der Zee H.H.
        • Laman J.D.
        • de Ruiter L.
        • et al.
        Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
        Br J Dermatol. 2012; 166: 298-305
        • Paradela S.
        • Rodríguez-Lojo R.
        • Fernández-Torres R.
        • et al.
        Long-term efficacy of infliximab in hidradenitis suppurativa.
        J Dermatolog Treat. 2012; 23: 278-283
        • Rambhatla P.V.
        • Lim H.W.
        • Hamzavi I.
        A systematic review of treatments for hidradenitis suppurativa.
        Arch Dermatol. 2012; 148: 439-446
        • Zhang Z.
        • Li C.
        • Zhao X.
        • Lv C.
        Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.
        Dig Dis Sci. 2012; 57: 2944-2954
        • Coukos J.A.
        • Howard L.A.
        • Weinberg J.M.
        ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.
        Dig Dis Sci. 2012; 57: 1544-1553
        • Dassopoulos T.
        • Nguyen G.C.
        • Talor M.V.
        • et al.
        NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.
        Am J Gastroenterol. 2010; 105: 378-386
        • Russell R.K.
        • Ip B.
        • Aldhous M.C.
        • et al.
        Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.
        J Pediatr Gastroenterol Nutr. 2009; 48: 161-167
        • Odes S.
        • Friger M.
        • Vardi H.
        • et al.
        Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease.
        Inflamm Bowel Dis. 2007; 13: 874-881
        • Hunger R.E.
        • Surovy A.M.
        • Hassan A.S.
        • et al.
        Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor.
        Br J Dermatol. 2008; 158: 691-697
        • Krause I.
        • Monselise Y.
        • Milo G.
        • Weinberger A.
        Anti-Saccharomyces cerevisiae antibodies: a novel serologic marker for Behçet's disease.
        Clin Exp Rheumatol. 2002; 20: S21-S24
        • Riente L.
        • Chimenti D.
        • Pratesi F.
        • et al.
        Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis.
        J Rheumatol. 2004; 31: 920-924
        • Mallant-Hent R.
        • Mary B.
        • von Blomberg E.
        • et al.
        Disappearance of anti- Saccharomyces cerevisiae antibodies in celiac disease during a gluten-free diet.
        Eur J Gastroenterol Hepatol. 2006; 18: 75-78
        • Sakly W.
        • Jeddi M.
        • Ghedira I.
        Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis.
        Dig Dis Sci. 2008; 53: 1983-1987
        • Muratori P.
        • Muratori L.
        • Guidi M.
        • et al.
        Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
        Clin Exp Immunol. 2003; 132: 473-476
        • Fagoonee S.
        • De Luca L.
        • De Angelis C.
        • et al.
        Anti Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis.
        Minerva Gastroenterol Dietol. 2009; 55: 37-40
        • Sakly W.
        • Mankaï A.
        • Sakly N.
        • et al.
        Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes.
        Endocr Pathol. 2010; 21: 108-114
        • YazÂc D.
        • AydÂn S.Z.
        • Yavuz D.
        • et al.
        Anti-Saccharomyces cerevisiae antibodies (ASCA) are elevated in autoimmune thyroid disease.
        Endocrine. 2010; 38: 194-198
        • van der Zee H.H.
        • van der Woude C.J.
        • Florencia E.F.
        • Prens E.P.
        Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study.
        Br J Dermatol. 2010; 162: 195-197
        • Zouboulis C.C.
        Update on hidradenitis suppurativa/acne inversa.
        in: Wolff K. Goldsmith L.A. Katz S.I. Gilchrest B.A. Paller A.S. Leffell D.J. Fitzpatrick's Dermatology in General Medicine. 7th ed. McGraw Hill, New York, Chicago2009